An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression

INTRODUCTION: IgA nephropathy (IgAN) is the most common glomerulonephritis with high risk of progression to end-stage renal disease in patients with proteinuria >1 g/24 hours. There are no known effective treatments in patients with IgAN. METHODS: We conducted a prospective open-label pilot study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Zand, Ladan, Canetta, Pietro, Lafayette, Richard, Aslam, Nabeel, Jan, Novak, Sethi, Sanjeev, Fervenza, Fernando C.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943772/
https://ncbi.nlm.nih.gov/pubmed/31922061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.10.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados